Literature DB >> 15959979

Haemorrhagic nephritis and enteritis of geese: pathomorphological investigations and proposed pathogenesis.

M Dobos-Kovács1, E Horváth, A Farsang, Edith Nagy, Andrea Kovács, F Szalai, S Bernáth.   

Abstract

Haemorrhagic nephritis and enteritis of geese as a new disease was first described in Hungary in 1969. The authors identified the causative agent of the outbreaks occurring in 1969 as a polyomavirus by PCR in 2001. In order to study the pathogenesis of the virus, one-day-old goslings were infected with tissue homogenate that tested positive for polyomavirus by PCR. Morphological, light and transmission electron microscopic (TEM) examinations have revealed that goose haemorrhagic polyomavirus replicates in the endothelial cells of the blood vessels and capillaries of diseased birds. Infection causes damage and necrosis of the endothelial cells. The virus was not observed in the parenchymal cells. Oedema and haemorrhages found throughout the body may be due to the dysfunction or functional deficiency of endothelial cells damaged by the virus.

Entities:  

Mesh:

Year:  2005        PMID: 15959979     DOI: 10.1556/AVet.53.2005.2.6

Source DB:  PubMed          Journal:  Acta Vet Hung        ISSN: 0236-6290            Impact factor:   0.955


  3 in total

Review 1.  Polyomaviruses of birds: etiologic agents of inflammatory diseases in a tumor virus family.

Authors:  Reimar Johne; Hermann Müller
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 2.  Pathogenicity of Avian Polyomaviruses and Prospect of Vaccine Development.

Authors:  Chen-Wei Wang; Yung-Liang Chen; Simon J T Mao; Tzu-Chieh Lin; Ching-Wen Wu; Duangsuda Thongchan; Chi-Young Wang; Hung-Yi Wu
Journal:  Viruses       Date:  2022-09-19       Impact factor: 5.818

3.  Genomic analysis of Sheldrake origin goose hemorrhagic polyomavirus, China.

Authors:  Chunhe Wan; Cuiteng Chen; Longfei Cheng; Rongchang Liu; Guanghua Fu; Shaohua Shi; Hongmei Chen; Qiuling Fu; Yu Huang
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.